Bionano Genomics (BNGO) Invested Capital (2017 - 2026)

Bionano Genomics' Invested Capital history runs 10 years deep, the most recent figure standing at $37.5 million for Q1 2026.

• In Q1 2026, Invested Capital fell 27.92% year-over-year to $37.5 million; the TTM figure through Mar 2026 stood at $37.5 million (down 27.92% YoY), while the FY2025 annual figure was $44.4 million, up 13.4% from the prior year.
• Invested Capital came in at $37.5 million for Q1 2026 at Bionano Genomics, down from $44.4 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $315.1 million in Q1 2022 to a low of $37.5 million in Q1 2026.
• A 5-year average of $136.4 million and a median of $86.6 million in 2024 frame the typical range for Invested Capital.
• Across the five-year window, Invested Capital sank 63.2% in 2024 and rose 13.4% in 2025, its largest moves.
• Bionano Genomics' Invested Capital stood at $253.3 million in 2022, then tumbled by 60.52% to $100.0 million in 2023, then sank by 60.83% to $39.2 million in 2024, then grew by 13.4% to $44.4 million in 2025, then dropped by 15.67% to $37.5 million in 2026.
• According to Business Quant data, Invested Capital over the past three periods registered $37.5 million, $44.4 million, and $53.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison